Análisis Argos
UHS
UHSOportunidad
Universal Health Services, Inc. · Healthcare
US$ 166.22
precio al 2026-07-28
Valor justo Argos*
US$ 151–185
vs. su valor justo
1% por debajo
Score Argos
67/100
Oportunidad
LA RESPUESTA
El mercado la precia para que crezca 6.9% al año — menos de lo que viene demostrando (8.9%). Un negocio de calidad castigado por expectativas pesimistas: por eso está entre las llamadas de Argos.
Recompensas
Cotiza por debajo de su valor justo: el mercado le pide menos crecimiento del que viene demostrando.
Las ganancias crecieron 30% el último año.
Riesgos
!Crecimiento estancado o en baja.
VALOR5/6FUTURO2/6PASADO5/6SALUD3/6DIVIDENDO5/6
El Iris de calidad
VALOR5/6FUTURO2/6PASADO5/6SALUD3/6DIVIDENDO5/6
ValorCotiza por debajo de su valor justo
FuturoCrecimiento moderado
PasadoFundamentales sólidos y sostenidos
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos67de 100Oportunidad
Ingresos10%
US$ 17.4 B
Margen operativo8%
11.5%
Flujo de caja libre24%
US$ 0.9 B
Deuda neta
US$ 5.4 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 10.1B
P/E6.8x
EV/EBITDA5.9x
FCF yield8.4%
ROIC12.1%
Margen operativo11.5%
Crecim. ingresos+9.7%/año
Piotroski F7/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

gurufocus.com · 28 jul
Is It Too Late to Buy Universal Health Services Inc (UHS) After 4.3% Rally? GF Value Says Undervalued
On July 28, 2026, Universal Health Services Inc (UHS) shares rose 4.3% to $166.22, showing a notable rebound over recent weeks. The stock has fluctuated within
marketbeat.com · 28 jul
Universal Health Services Q2 Earnings Call Highlights
Universal Health Services NYSE: UHS reported second-quarter adjusted earnings per share of $5.98, up 12% from a year earlier, while adjusted EBITDA less noncontrolling interests rose 5% to $678 million. The company said results benefited from a $100 million out-of-period Florida directed payment program benefit that had not been included in its original outlook.
seekingalpha.com · 28 jul
Universal Health Services, Inc. (UHS) Q2 2026 Earnings Call Transcript
Universal Health Services, Inc. (UHS) Q2 2026 Earnings Call Transcript
zacks.com · 28 jul
UHS Beats Q2 Earnings and Revenue Estimates Despite Cost Pressures
UHS tops Q2 earnings and revenue estimates as Acute Care and Behavioral Health growth lifts results, even as higher costs weigh on operations.
zacks.com · 27 jul
Universal Health Services (UHS) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Universal Health Services (UHS) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zacks.com · 27 jul
Universal Health Services (UHS) Q2 Earnings and Revenues Top Estimates
Universal Health Services (UHS) came out with quarterly earnings of $5.98 per share, beating the Zacks Consensus Estimate of $5.66 per share. This compares to earnings of $5.35 per share a year ago.
reuters.com · 27 jul
Universal Health Services cuts 2026 forecast on Medicaid reimbursement uncertainty
Hospital operator Universal Health Services lowered its full-year profit forecast on Monday, citing changes in ​reimbursements related to certain Medicaid supplemental payment ‌programs, sending its shares down nearly 8% in extended trading.
prnewswire.com · 27 jul
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026, AND REVISES 2026 FULL YEAR OPERATING RESULTS FORECAST
Consolidated Results of Operations, As Reported and As Adjusted  – Three-month periods ended June 30, 2026 and 2025: KING OF PRUSSIA, Pa., July 27, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $358.4 million, or $5.98 per diluted share, during the second quarter of 2026, as compared to $353.2 million, or $5.43 per diluted share, during the second quarter of 2025.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.